Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Authors : Kausik K Ray, Helen M Colhoun, Michael Szarek, Marie Baccara-Dinet, *Denis Xavier*, et al..
Publication Year : 2019
Abstract :
https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30158-5/abstract